|meds and theraphie are good?
Jan 19, 2003
hi!My child is infected with hiv and i m wondering how long it will take to discover a surely vaccine ? My son is taking meds for 5 yearswith 3 changes of therapies . There would be the chance for one more theraphie?thank you .
| Response from Dr. Boyle
A therapeutic vaccine is still some ways off, but progress is being made and some recent data support some optimism regarding this potential therapy. In addition, there are a number of drugs in the HIV therapy pipeline that will treat multi-drug resistant HIV, so even patients with significant resistance to the currently available drugs can look forward to some new drugs that should help to control their HIV. Drugs likely to be approved this year include FOS-amprenavir (amprenavir prodrug), atazanavir (a new protease inhibitor), emtricitabine (a nucleoside analogue similar to 3TC but with a longer half-life), and enfuvirtide (T-20, a fusion inhibitor that blocks HIV from entering the cell and is effective even in patients with a lot of resistance). Zerit XR, a once daily formulation of Zerit, just got approved. Drugs in the pipeline that are in late development and will have some effectiveness against resistant HIV include tipranavir (a protease inhibitor), TMC-125 (a non-nucleoside), and DAPD (a nucleoside analogue). So, you can expect a growing number of effective options and things should continue to improve.
Get Email Notifications When This Forum Updates or Subscribe With RSS
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.